Clinical efficacy and safety of novel antibiotics for complicated urinary tract infection: A systematic review and meta-analysis of randomized controlled trials
KC Hung, WW Tsai, CW Hsu, CC Lai, HJ Tang… - International Journal of …, 2023 - Elsevier
Objective To assess the clinical efficacy and safety of novel antibiotics for complicated
urinary tract infections (cUTIs). Methods Three electronic databases (Medline, Embase and …
urinary tract infections (cUTIs). Methods Three electronic databases (Medline, Embase and …
Efficacy and safety of carbapenems vs new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis
Y Ezure, V Rico, DL Paterson, L Hall… - Open Forum …, 2022 - academic.oup.com
This systematic review and meta-analysis evaluated the clinical efficacy and safety of
carbapenems for the treatment of complicated urinary tract infections (cUTIs), with the …
carbapenems for the treatment of complicated urinary tract infections (cUTIs), with the …
A review of recent advances in the treatment of adults with complicated urinary tract infection
Introduction Complicated urinary tract infections (cUTIs) entail diverse clinical conditions that
could be managed differently and not necessarily with premature empiric therapy. Since …
could be managed differently and not necessarily with premature empiric therapy. Since …
Carbapenems vs alternative antibiotics for the treatment of complicated urinary tract infection: A systematic review and network meta-analysis
X Tan, Q Pan, C Mo, X Li, X Liang, Y Li, Y Lan, L Chen - Medicine, 2020 - journals.lww.com
Background: Complicated urinary tract infections (cUTI) are universal reasons for
hospitalization, and highly likely to develop into sepsis or septic shock. Carbapenem …
hospitalization, and highly likely to develop into sepsis or septic shock. Carbapenem …
Antibiotics efficacy in clinical and microbiological cure of uncomplicated urinary tract infection: a systematic review and network meta-analysis
MF Hadidi, N Alhamami, M Alhakami… - World Journal of …, 2024 - Springer
Purpose Fosfomycin has been used more frequently in managing uncomplicated urinary
tract infections (UTIs) due to decreased compliance and increased multidrug-resistant …
tract infections (UTIs) due to decreased compliance and increased multidrug-resistant …
Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria …
Introduction Complicated urinary tract infections (cUTIs) are associated with poor prognosis.
The widespread infection of multidrug-resistant Gram-negative uropathogens such as …
The widespread infection of multidrug-resistant Gram-negative uropathogens such as …
An update on emerging therapies for urinary tract infections
A Majeed, S Alarfaj, R Darouiche… - Expert Opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: Urinary tract infections (UTIs) are the most common healthcare-
acquired infections, and are associated with high morbidity and mortality. Worldwide use of …
acquired infections, and are associated with high morbidity and mortality. Worldwide use of …
Emerging drugs for bacterial urinary tract infections
FME Wagenlehner, W Weidner… - Expert Opinion on …, 2005 - Taylor & Francis
Bacterial urinary tract infections (UTIs) are frequent infections in the outpatient as well as in
the nosocomial setting. The stratification into uncomplicated and complicated UTIs has …
the nosocomial setting. The stratification into uncomplicated and complicated UTIs has …
Comparative effectiveness of antibiotics for uncomplicated urinary tract infections: network meta-analysis of randomized trials
BJ Knottnerus, L Grigoryan, SE Geerlings… - Family …, 2012 - academic.oup.com
Background The efficacies and adverse effects of different antibiotics for uncomplicated
urinary tract infections (UTIs) have been studied by standard meta-analytic methods using …
urinary tract infections (UTIs) have been studied by standard meta-analytic methods using …
Novel antibiotics in the treatment of urinary tract infections
KG Naber, FME Wagenlehner - European Urology Focus, 2019 - Elsevier
Conclusions Several new antibiotic agents are currently close to being marketed or are in
the late clinical phase of development. However, unique novel compounds are rare, so …
the late clinical phase of development. However, unique novel compounds are rare, so …